Sermorelin Benefits: What the Research Shows

Disclosure: This post contains affiliate links. We may earn a commission if you purchase through our links, at no extra cost to you.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Sermorelin benefits are mostly claimed, not proven. In published trials, sermorelin and similar growth hormone releasing hormone (GHRH) peptides raised GH release, with IGF-1 levels rising in some studies and not in others, but small studies in older people found limited or mixed changes in muscle, body fat, sleep, well-being, skin and libido. This page checks each claim you see on clinic pages against the research, grades it as studied, limited or not shown, and says who was enrolled. I am not a clinician, so each claim here names the study or FDA page it comes from, and every source is linked in the tables and the Sources list.

For the full picture of the peptide, start with my sermorelin therapy overview. This page covers only the benefits.

What is sermorelin, and what was it approved for?

Sermorelin is a synthetic peptide with the same sequence as the first 29 amino acids of GHRH, according to a 2003 review in Advanced Drug Delivery Reviews. A 1999 BioDrugs review describes it as stimulating growth hormone (GH) release from the pituitary, used to test for GH deficiency and to treat some children with idiopathic GH deficiency. Transient facial flushing and injection site pain were the most commonly reported side effects.

The FDA’s March 4, 2013 Federal Register notice says Geref (sermorelin acetate) was approved in 1990 for evaluating whether the pituitary can secrete GH and in 1997 for children with growth failure from idiopathic GH deficiency. It says the manufacturer, EMD Serono, notified FDA in 2008 that the products were being discontinued and asked for approval to be withdrawn, that approval was withdrawn effective June 18, 2009, and that FDA determined the products were not withdrawn for reasons of safety or effectiveness. Neither approved use was anti-aging, fat loss or muscle building.

FDA’s Drugs@FDA data, read through openFDA on October 26, 2026, lists only those two Geref applications for sermorelin acetate, both marked discontinued. If a clinic offers compounded sermorelin, FDA’s compounding questions and answers page says compounded drugs are not FDA-approved and that FDA does not verify their safety, effectiveness or quality before they are marketed.

How are the sermorelin benefits graded?

Studied means at least one controlled human trial measured the outcome and reported a benefit. Limited means the evidence is small, short, mixed, or found in one group only. Not shown means the trials cited here measured it and saw no change, or none of them measured it. Three trials used GHRH 1-29 or a close analog (Corpas, Vittone, Khorram). The two sleep lab trials (Schussler, Antonijevic) say only “GHRH” in their abstracts, and one trial (Baker) used tesamorelin, a different drug, which I label where it appears.

Claimed benefit	What the cited trials found	Grade
More GH	GH release rose in older men and in people aged 55 to 71	Studied (a lab result, not something you feel)
Muscle	Two of six strength tests improved in one 6 week trial; lean mass rose in men only in another	Limited
Weight and fat	Body weight and fat did not move in the sermorelin type trials	Not shown
Sleep	Questionnaires showed no change; in sleep lab nights, one study found more non-REM sleep after GHRH and another found it rose in men and fell in women	Limited
Well-being (energy was not reported separately)	Well-being improved in men, not women	Limited
Skin	Skin thickness increased; wrinkles were not reported	Limited
Libido	Improved in men, not women	Limited
Hair and workout recovery	Not measured in the trials cited here	Not shown

Who did the sermorelin and GHRH trials enroll?

The trials were small, short and mostly in older people. The largest trial in this table, with 152 participants, tested tesamorelin, a different drug. The largest that used GHRH or a GHRH analog had 48 participants, and the longest ran about 5 months.

Trial	Who was enrolled	What was given
Corpas and colleagues, 1992	10 older men, average age 68, compared with 9 young men	GHRH 1-29 injected twice daily for 14 days at two doses
Vittone and colleagues, 1997	11 men aged 64 to 76 with low IGF-1	GHRH 1-29, 2 mg injected nightly for 6 weeks
Khorram and colleagues, 1997	19 people aged 55 to 71, 10 women and 9 men	4 weeks of placebo, then a GHRH 1-29 analog nightly for 16 weeks, single-blind
Schussler and colleagues, 2006	48 women and men aged 19 to 67	Repeated GHRH injections on a recovery night after 40 hours without sleep
Baker and colleagues, 2012	152 people aged 55 to 87, 66 with mild cognitive impairment	Tesamorelin, a different GHRH analog, daily for 20 weeks

Does sermorelin raise growth hormone?

Yes, and this is the best supported finding, but it is a lab result and not a benefit you feel. In the 1992 trial, the high dose of GHRH 1-29 (1 mg twice daily for 14 days) raised 24 hour GH and IGF-1 in the older men to levels that no longer differed from the young men. In the Khorram trial, nightly dosing raised nighttime GH in both women and men, and IGF-1 rose within 2 weeks, stayed up for 12 weeks and returned toward baseline by week 16. In the Vittone trial, nightly dosing raised GH release but did not change IGF-1.

A 2026 narrative review in Sexual Medicine Reviews reached a similar conclusion: the secretagogues it searched, a group that included sermorelin, increase GH and IGF-1, but evidence for better sexual function, physical performance or quality of life remains limited.

Does sermorelin build muscle?

The evidence is limited. In the Vittone trial, two of six strength tests (upright row and shoulder press) and one endurance test (abdominal crunch) improved after 6 weeks, but DEXA scan measures of muscle and fat did not change. In the Khorram trial, lean body mass rose in men only, with no other body composition change in either sex.

Mayo Clinic’s page on human growth hormone and aging (November 6, 2024) says injected GH appears to boost muscle mass in older people without gains in strength. That page covers GH itself, not sermorelin.

Does sermorelin burn fat or help with weight loss?

Not in the trials cited here. Body weight was unaffected in the Khorram trial, and the Vittone trial found no change in weight, body mass index, waist to hip ratio or DEXA fat. A GHRH analog with a fat related FDA label, tesamorelin, is a different drug. The 2025 label for tesamorelin (Egrifta WR) is indicated for reducing excess abdominal fat in HIV-infected adults with lipodystrophy, and it says the drug is not indicated for weight loss management because its effect on weight is neutral (FDA label, revised March 2025).

The 20 week tesamorelin trial did report a 7.4 percent reduction in percent body fat, but that was a different drug. A systematic review of injected GH in older people found about 2.1 kg less fat mass and 2.1 kg more lean mass with no change in body weight, along with more edema, joint pain and carpal tunnel syndrome (Liu and colleagues, Annals of Internal Medicine, 2007).

Drugs tested for weight loss look different. In the STEP 1 trial, 1,961 people without diabetes lost an average of 14.9 percent of body weight on semaglutide 2.4 mg over 68 weeks, compared with 2.4 percent on placebo (New England Journal of Medicine, 2021). My GLP-1 weight loss guide and my best peptides for weight loss page cover that comparison.

Does sermorelin improve sleep?

The evidence is limited and mixed. In the Khorram trial, questionnaires showed sleep quality was unaffected in both women and men. In sleep recordings, GHRH given to 48 women and men during a recovery night after sleep deprivation increased non-REM sleep more than placebo did (Schussler and colleagues, 2006; the abstract says only “GHRH”).

Sex differences matter here. In a 2000 study of patients with depression and controls aged 19 to 76, GHRH injected four times in the evening enhanced non-REM sleep in men and decreased it in women (Antonijevic and colleagues). These were sleep lab studies of nights when GHRH was injected, not months of treatment.

Does sermorelin boost energy and well-being?

Limited. The only trial cited here that measured general well-being found a significant improvement in men but not in women (Khorram, 1997). Energy was not reported as a separate outcome.

Does sermorelin improve skin?

Limited. The Khorram trial measured skin thickness with calipers at four sites, including the hands and forearms, and found a significant increase in women and men. Thicker skin on a caliper is not the same as fewer wrinkles or better elasticity, and the abstract does not report either.

Does sermorelin improve libido?

Limited, and in men only. In the Khorram trial libido improved in men (P below .01) and not in women. The 2026 Sexual Medicine Reviews paper above found limited evidence that these peptides improve sexual function.

What about cognition, hair and recovery?

Cognition was tested with tesamorelin, not sermorelin. In the 2012 Archives of Neurology trial, 20 weeks of daily tesamorelin had a favorable effect on cognition, and mild adverse events were reported by 68 percent of the treated group and 36 percent of the placebo group. None of the sermorelin type trials cited here measured hair growth or workout recovery.

Do sermorelin benefits differ for women?

Of the body-composition and quality-of-life trials, only Khorram enrolled women, and it found fewer effects in them. In Khorram, lean mass, insulin sensitivity, well-being and libido improved in men but not in women, though skin thickness rose in both. The women were aged 55 to 71. If you are in the menopause transition, my guide to weight loss during menopause covers what the research does support.

What are the risks and side effects of sermorelin?

In the Khorram trial, the only adverse effect was transient hyperlipidemia that resolved by the end of the study, and the Vittone trial reported no significant adverse effects. Those trials ran 6 weeks and 5 months, so they say little about years of use. A 2026 review in Frontiers in Endocrinology of peptides marketed as performance enhancers describes uncertainty about product composition and dose in unregulated supply chains. See my sermorelin side effects page for more.

What do sellers claim about sermorelin?

On its sermorelin page, read on October 26, 2026, GobyMeds lists these benefits: lean muscle and endurance, fat reduction while preserving muscle, better sleep including REM cycles, improved skin elasticity and fewer wrinkles, stronger nails and hair, mental focus, cardiovascular, immune and bone support, and libido. The page says an intake form helps decide whether sermorelin is right for you and does not say whether its product is compounded. Those are the company’s statements.

The FDA has also commented on this kind of marketing. In a December 10, 2024 warning letter to Xcel Research LLC, FDA quoted the seller’s site as saying sermorelin gives “enhanced muscle growth and repair” and has “potential to improve metabolism and aid in fat loss”, said the product is not generally recognized as safe and effective for those uses, and said no FDA-approved application is in effect for it. That letter concerned one company’s website. For how access works, see my guide on how to get sermorelin.

Please talk to your prescriber or pharmacist before considering any peptide, especially if you take a GLP-1 or other prescription medicine. This page is research, not medical advice.

Frequently Asked Questions

Which sermorelin benefit has the best evidence?

The rise in GH release is the best documented effect. Benefits you could notice, such as muscle, sleep, well-being, skin and libido, rest on small, short trials with limited or mixed results.

Is sermorelin the same as HGH?

No. Sermorelin is a GHRH peptide that stimulates the pituitary to release GH. HGH is the hormone itself. Mayo Clinic says experts recommend against using HGH to treat aging and lists side effects of HGH such as carpal tunnel syndrome, high blood sugar and edema.

Is sermorelin a weight loss drug?

The trials cited here do not show that it is. Body weight did not change in the sermorelin type trials, and the FDA label for tesamorelin, a related drug, says it is not indicated for weight loss management. Medicines studied for weight loss, such as semaglutide in the STEP 1 trial, measured weight directly.

Can sermorelin help women over 40 sleep better?

The research does not answer that. The Khorram trial found no change in women’s sleep questionnaires, and a lab study found GHRH decreased non-REM sleep in women while enhancing it in men. The Khorram women were aged 55 to 71 and the lab studies covered ages 19 to 76, so none isolates women in their 40s.

Who has actually been studied with sermorelin?

Children with idiopathic GH deficiency, for the approved Geref products, and small groups of adults, two of the trials men only, given GHRH 1-29, a GHRH analog or an unspecified GHRH in the research trials above. The one larger trial tested tesamorelin. The 2013 FDA notice and the 1999 BioDrugs review describe the pediatric and diagnostic uses.

Sources

Sermorelin Benefits: Claim-by-Claim Check Against the Research